Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD24 Ala/Val polymorphism and multiple sclerosis.

An Goris1, Melanie Maranian, Amie Walton

  • 1Department of Clinical Neurosciences, Neurology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. ag441@medschl.cam.ac.uk

Journal of Neuroimmunology
|April 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motor learning strategies during walking with error and reinforcement feedback in healthy older adults.

Gait & posture·2026
Same author

Epstein-Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression.

Immunity, inflammation and disease·2026
Same author

Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Federated single-cell QTL meta-analysis reveals novel disease mechanisms.

bioRxiv : the preprint server for biology·2026
Same author

Human adenosine deaminase type 2 deficiency enhances NK cell activation but impairs maturation and function.

The Journal of clinical investigation·2026
Same author

Listeria monocytogenes rhombencephalitis: a case report and review of current literature.

Acta clinica Belgica·2025
Same journal

Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

Journal of neuroimmunology·2026
Same journal

Serum IDO1 and β-catenin levels in patients with multiple sclerosis with and without atherosclerosis: A case-control study.

Journal of neuroimmunology·2026
Same journal

Neurological sequelae of Long COVID: Pathophysiological mechanisms, diagnostic advances, and therapeutic perspectives.

Journal of neuroimmunology·2026
Same journal

Corrigendum to 'Role of CD40 in prion disease and the immune response to recombinant PrP' [Journal of Neuroimmunology 257 (2013) 21-27/475655].

Journal of neuroimmunology·2026
Same journal

Clinical characteristics of IgG4-related hypertrophic pachymeningitis with and without serum ANCA positivity.

Journal of neuroimmunology·2026
Same journal

Chronic neuroinflammation after acute SARS-Cov-2 infection induces retinal damage in the hACE2 transgenic mouse model.

Journal of neuroimmunology·2026
See all related articles

Researchers investigated the CD24 gene

Area of Science:

  • Neuroimmunology
  • Genetics

Background:

  • CD24 is expressed in immune and central nervous systems.
  • CD24 plays a role in experimental autoimmune encephalomyelitis.
  • A CD24 polymorphism was previously linked to multiple sclerosis (MS).

Purpose of the Study:

  • To investigate the association of a CD24 Ala/Val polymorphism with multiple sclerosis (MS).

Main Methods:

  • Genotyping of the CD24 Ala/Val polymorphism in a cohort of 1,180 MS cases and 1,168 controls from Belgium and the UK.
  • Careful SNP identification and genotyping due to the CD24 gene's location within a segmental duplication.

Main Results:

  • The study did not confirm the association between the CD24 Ala/Val polymorphism and multiple sclerosis susceptibility or progression.

Related Experiment Videos

  • The CD24 gene's location within a segmental duplication poses challenges for accurate genotyping.

    • Conclusions:

    • The CD24 Ala/Val polymorphism is not associated with multiple sclerosis in the studied populations.
    • Further research with advanced genotyping methods may be needed to clarify CD24's role in MS.